Keyword search (4,163 papers available)

"Wood K" Authored Publications:

Title Authors PubMed ID
1 Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research Smith EE; Phillips NA; Feldman HH; Borrie M; Ganesh A; Henri-Bhargava A; Desmarais P; Frank A; Badhwar A; Barlow L; Bartha R; Best S; Bethell J; Bhangu J; Black SE; Bocti C; Bronskill SE; Burhan AM; Calon F; Camicioli R; Campbell B; Collins DL; Dadar M; DeMarco ML; Ducharme S; Duchesne S; Einstein G; Fisk JD; Gawryluk JR; Grossman L; Ismail Z; Itzhak I; Joshi M; Harrison A; Kroger E; Kumar S; Laforce R; Lanctot KL; Lau M; Lee L; Masellis M; Massoud F; Mitchell SB; Montero-Odasso M; Myers Barnett K; Nygaard HB; Pasternak SH; Peters J; Rajah MN; Robillard JM; Rockwood K; Rosa-Neto P; Seitz DP; Soucy JP; Trenaman SC; Wellington CL; Zadem A; Chertkow H; 39893139
CONCORDIA
2 Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA) Chertkow H; Phillips N; Rockwood K; Anderson N; Andrew MK; Bartha R; Beaudoin C; Bélanger N; Bellec P; Belleville S; Bergman H; Best S; Bethell J; Bherer L; Black S; Borrie M; Camicioli R; Carrier J; Cashman N; Chan S; Crowshoe L; Cuello C; Cynader M; Dang-Vu T; Das S; Dixon RA; Ducharme S; Einstein G; Evans AC; Fahnestock M; Feldman H; Ferland G; Finger E; Fisk JD; Fogarty J; Fon E; Gan-Or Z; Gauthier S; Greenwood C; Henri-Bellemare C; Herrmann N; Hogan DB; Hsiung R; Itzhak I; Jacklin K; Lanctôt K; Lim A; MacKenzie I; Masellis M; Maxwell C; McAiney C; McGilton K; McLaurin J; Mihailidis A; Mohades Z; Montero-Odasso M; Morgan D; Naglie G; Nygaard H; O' Connell M; Petersen R; Pilon R; Rajah MN; Rapoport M; Roach P; Robillard JM; Rogaeva E; Rosa-Neto P; Rylett J; Sadavoy J; St George-Hyslop P; Seitz D; Smith E; Stefanovic B; Vedel I; Walker JD; Wellington C; Whitehead V; Wittich W; 39636028
HKAP
3 Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab Chertkow H; Rockwood K; Hogan DB; Phillips N; Montero-Odasso M; Amanullah S; Black S; Bocti C; Borrie M; Feldman H; Freedman M; Hsiung R; Kirk A; Masellis M; Nygaard H; Rajji T; Verret L; 34912492
PSYCHOLOGY
4 A comprehensive investigation of industrial plastic pellets on beaches across the Laurentian Great Lakes and the factors governing their distribution. Corcoran PL, de Haan Ward J, Arturo IA, Belontz SL, Moore T, Hill-Svehla CM, Robertson K, Wood K, Jazvac K 32781316
CONCORDIA
5 Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia. Ismail Z, Black SE, Camicioli R, Chertkow H, Herrmann N, Laforce R, Montero-Odasso M, Rockwood K, Rosa-Neto P, Seitz D, Sivananthan S, Smith EE, Soucy JP, Vedel I, Gauthier S, CCCDTD5 participants 32725777
PERFORM
6 Clinical judgement is paramount when performing cognitive screening during COVID-19. Phillips NA, Andrews M, Chertkow H, Pichora-Fuller MK, Rockwood K, Wittich W 32396983
PSYCHOLOGY
7 The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Phillips NA, MacNamara E, Dixon RA, Duchesne S, MacKenzie I, Rylett RJ 31309917
PSYCHOLOGY
8 Embracing an interdisciplinary approach to plastics pollution awareness and action. Belontz SL, Corcoran PL, Davis H, Hill KA, Jazvac K, Robertson K, Wood K 30448996
BIOLOGY

 

Title:The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.
Authors:Chertkow HBorrie MWhitehead VBlack SEFeldman HHGauthier SHogan DBMasellis MMcGilton KRockwood KTierney MCAndrew MHsiung GRCamicioli RSmith EEFogarty JLindsay JBest SEvans ADas SMohaddes ZPilon RPoirier JPhillips NAMacNamara EDixon RADuchesne SMacKenzie IRylett RJ
Link:https://www.ncbi.nlm.nih.gov/pubmed/31309917?dopt=Abstract
DOI:10.1017/cjn.2019.27
Publication:The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Keywords:AlzheimersBiomarkersCohort studyDementiaDiagnosisFrontotemporal dementia
PMID:31309917 Category:Can J Neurol Sci Date Added:2019-08-07
Dept Affiliation: PSYCHOLOGY
1 Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
2 Lady Davis Institute, Montreal, Quebec, Canada.
3 Department of Geriatric Medicine, Western University, London, Ontario, Canada.
4 Lawson Health Research Institute, London, Ontario, Canada.
5 Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
6 Sunnybrook Research Institute, Toronto, Ontario, Canada.
7 Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
8 Department of Neurosciences, University of California, San Diego, California, USA.
9 The Hotchkiss Brain Institute, Calgary, Alberta, Canada.
10 Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
11 McGill Center for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada.
12 Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
13 Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.
14 Toronto Rehabilitation Institute, Toronto, Ontario, Canada.
15 Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
16 Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
17 Department of Physiology and Pharmacology, Western University, London, Ontario, Canada.
18 Robarts Research, London, Ontario, Canada.
19 Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
20 Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
21 Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada.
22 Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
23 Department of Psychiatry, Western University, London, Ontario, Canada.
24 McConnell Brain Imaging Centre, McGill University, Montreal, Quebec, Canada.
25 McGill Centre for Integrative Neuroscience, Montreal, Quebec, Canada.
26 Department of Psychology, Concordia University, Montreal, Quebec, Canada.
27 Department of Medicine, McGill University, Montreal, Quebec, Canada.
28 Department of Psychology, University of Alberta, Edmonton, Alberta, Canada.
29 Department of Radiology, Laval University, Quebec City, Quebec, Canada.
30 Centre de recherche de l'Institut universitaire en santé mentale de Québec, Université Laval, Québec City, Québec, Canada.
31 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Description:

The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.

Can J Neurol Sci. 2019 Jul 16;:1-13

Authors: Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Phillips NA, MacNamara E, Dixon RA, Duchesne S, MacKenzie I, Rylett RJ

Abstract

BACKGROUND: The Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND) cohort study of the Canadian Consortium on Neurodegeneration in Aging (CCNA) is a national initiative to catalyze research on dementia, set up to support the research agendas of CCNA teams. This cross-country longitudinal cohort of 2310 deeply phenotyped subjects with various forms of dementia and mild memory loss or concerns, along with cognitively intact elderly subjects, will test hypotheses generated by these teams.

METHODS: The COMPASS-ND protocol, initial grant proposal for funding, fifth semi-annual CCNA Progress Report submitted to the Canadian Institutes of Health Research December 2017, and other documents supplemented by modifications made and lessons learned after implementation were used by the authors to create the description of the study provided here.

RESULTS: The CCNA COMPASS-ND cohort includes participants from across Canada with various cognitive conditions associated with or at risk of neurodegenerative diseases. They will undergo a wide range of experimental, clinical, imaging, and genetic investigation to specifically address the causes, diagnosis, treatment, and prevention of these conditions in the aging population. Data derived from clinical and cognitive assessments, biospecimens, brain imaging, genetics, and brain donations will be used to test hypotheses generated by CCNA research teams and other Canadian researchers. The study is the most comprehensive and ambitious Canadian study of dementia. Initial data posting occurred in 2018, with the full cohort to be accrued by 2020.

CONCLUSION: Availability of data from the COMPASS-ND study will provide a major stimulus for dementia research in Canada in the coming years.

PMID: 31309917 [PubMed - as supplied by publisher]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University